日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Indolethylamine N-Methyltransferase Deletion Impacts Mouse Behavior without Disrupting Endogenous Psychedelic Tryptamine Production

吲哚乙胺N-甲基转移酶缺失会影响小鼠行为,但不会影响内源性迷幻色胺的产生。

Hatzipantelis, Cassandra J; Cameron, Lindsay P; Liu, Min; Patel, Seona D; Saeger, Hannah N; Vernier, Anna M M; Khatib, Yara A; Willis, Brandon J; Lanoue, Louise; Fiehn, Oliver; Olson, David E

Psychoplastogenic DYRK1A Inhibitors with Therapeutic Effects Relevant to Alzheimer's Disease.

具有治疗阿尔茨海默病作用的心理可塑性DYRK1A抑制剂

Warren Hunter T, Saeger Hannah N, Tombari Robert J, Chytil Milan, Rasmussen Kurt, Olson David E

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

迷幻剂通过激活细胞内5-HT2A受体促进神经可塑性。

Vargas, Maxemiliano V; Dunlap, Lee E; Dong, Chunyang; Carter, Samuel J; Tombari, Robert J; Jami, Shekib A; Cameron, Lindsay P; Patel, Seona D; Hennessey, Joseph J; Saeger, Hannah N; McCorvy, John D; Gray, John A; Tian, Lin; Olson, David E

5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines

5-HT2ARs介导迷幻色胺的治疗行为效应

Cameron, Lindsay P; Patel, Seona D; Vargas, Maxemiliano V; Barragan, Eden V; Saeger, Hannah N; Warren, Hunter T; Chow, Winston L; Gray, John A; Olson, David E

Psychedelic-inspired approaches for treating neurodegenerative disorders

受迷幻药启发而提出的治疗神经退行性疾病的方法

Saeger, Hannah N; Olson, David E